EJ Begg

1.1k total citations
19 papers, 851 citations indexed

About

EJ Begg is a scholar working on Pediatrics, Perinatology and Child Health, Pharmacology and Pharmacology. According to data from OpenAlex, EJ Begg has authored 19 papers receiving a total of 851 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pediatrics, Perinatology and Child Health, 6 papers in Pharmacology and 6 papers in Pharmacology. Recurrent topics in EJ Begg's work include Pharmaceutical studies and practices (6 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Drug Transport and Resistance Mechanisms (4 papers). EJ Begg is often cited by papers focused on Pharmaceutical studies and practices (6 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Drug Transport and Resistance Mechanisms (4 papers). EJ Begg collaborates with scholars based in New Zealand and Australia. EJ Begg's co-authors include Stephen B. Duffull, Murray L. Barclay, Rebecca L Roberts, Peter R. Joyce, Roger Mulder, Martin A. Kennedy, RA Robson, Charles R. Webb, Richard O. Day and G. Mark Jeffery and has published in prestigious journals such as British Journal of Clinical Pharmacology, Clinical and Experimental Pharmacology and Physiology and The Pharmacogenomics Journal.

In The Last Decade

EJ Begg

18 papers receiving 794 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
EJ Begg New Zealand 13 283 214 178 158 128 19 851
Leon J. Dusci Australia 21 274 1.0× 207 1.0× 96 0.5× 46 0.3× 163 1.3× 57 1.2k
Karen I. Plaisance United States 17 434 1.5× 112 0.5× 239 1.3× 132 0.8× 207 1.6× 30 1.2k
Yukinao Kohda Japan 19 139 0.5× 253 1.2× 103 0.6× 150 0.9× 153 1.2× 115 1.3k
David M. Cocchetto United States 17 285 1.0× 73 0.3× 191 1.1× 120 0.8× 188 1.5× 40 1.4k
Jean‐Guy Besner Canada 18 191 0.7× 261 1.2× 52 0.3× 105 0.7× 174 1.4× 39 1.1k
Anup Majumdar United States 20 388 1.4× 147 0.7× 112 0.6× 144 0.9× 110 0.9× 49 1.3k
Marc G. Bogaert Belgium 21 282 1.0× 145 0.7× 77 0.4× 191 1.2× 243 1.9× 85 1.5k
A. J. McLean Australia 17 142 0.5× 80 0.4× 181 1.0× 126 0.8× 133 1.0× 45 914
John H. Cavanaugh United States 23 222 0.8× 351 1.6× 173 1.0× 143 0.9× 156 1.2× 59 1.7k
Fabienne Péhourcq France 24 324 1.1× 89 0.4× 89 0.5× 120 0.8× 244 1.9× 57 1.5k

Countries citing papers authored by EJ Begg

Since Specialization
Citations

This map shows the geographic impact of EJ Begg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by EJ Begg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites EJ Begg more than expected).

Fields of papers citing papers by EJ Begg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by EJ Begg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by EJ Begg. The network helps show where EJ Begg may publish in the future.

Co-authorship network of co-authors of EJ Begg

This figure shows the co-authorship network connecting the top 25 collaborators of EJ Begg. A scholar is included among the top collaborators of EJ Begg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with EJ Begg. EJ Begg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Begg, EJ. (2005). Individualized drug and dose: The clinical pharmacologist's calling or curse?. Clinical and Experimental Pharmacology and Physiology. 32(11). 975–978. 3 indexed citations
2.
Roberts, Rebecca L, Peter R. Joyce, Roger Mulder, EJ Begg, & Martin A. Kennedy. (2002). A common P-glycoprotein polymorphism is associated with nortriptyline-induced postural hypotension in patients treated for major depression. The Pharmacogenomics Journal. 2(3). 191–196. 164 indexed citations
3.
Begg, EJ, RA Robson, Sharon J. Gardiner, et al.. (2001). Quinapril and its metabolite quinaprilat in human milk. British Journal of Clinical Pharmacology. 51(5). 478–481. 16 indexed citations
4.
Gardiner, Sharon J., Carl M. J. Kirkpatrick, & EJ Begg. (2001). Fifteen years of drug information in Christchurch Hospital.. PubMed. 114(1139). 393–5.
5.
Begg, EJ, Murray L. Barclay, & Stephen B. Duffull. (1995). A suggested approach to once‐daily aminoglycoside dosing.. British Journal of Clinical Pharmacology. 39(6). 605–609. 345 indexed citations
6.
Begg, EJ, et al.. (1994). The pharmacokinetics of quinapril and quinaprilat in patients with congestive heart failure.. British Journal of Clinical Pharmacology. 37(3). 302–304. 8 indexed citations
7.
Begg, EJ, Richard A. Robson, C. Frampton, & Janice Campbell. (1992). A comparison of efficacy and tolerance of the short acting sedatives midazolam and zopiclone.. PubMed. 105(944). 428–9. 12 indexed citations
8.
Begg, EJ, et al.. (1992). Prospective evaluation of a model for the prediction of milk:plasma drug concentrations from physicochemical characteristics.. British Journal of Clinical Pharmacology. 33(5). 501–505. 72 indexed citations
9.
Begg, EJ, et al.. (1990). The pharmacokinetics and pharmacodynamics of quinapril and quinaprilat in renal impairment.. British Journal of Clinical Pharmacology. 30(2). 213–220. 27 indexed citations
11.
Begg, EJ, et al.. (1989). The pharmacokinetics of angiotensin converting enzyme inhibitors in patients with renal impairment.. PubMed. 7(5). S29–32. 18 indexed citations
12.
Begg, EJ, et al.. (1989). Variability in the elimination of mianserin in elderly patients.. British Journal of Clinical Pharmacology. 27(4). 445–451. 15 indexed citations
13.
Begg, EJ, et al.. (1988). The binding of drugs to major human milk whey proteins.. British Journal of Clinical Pharmacology. 26(1). 107–109. 26 indexed citations
14.
Begg, EJ, et al.. (1988). Prediction of drug concentrations in human skim milk from plasma protein binding and acid‐base characteristics.. British Journal of Clinical Pharmacology. 25(4). 495–503. 37 indexed citations
15.
Begg, EJ, et al.. (1986). Renal failure does not impair the metabolism of morphine.. British Journal of Clinical Pharmacology. 22(1). 55–59. 37 indexed citations
16.
Begg, EJ, et al.. (1985). Possible mechanism for mianserin induced neutropenia associated with saturable elimination kinetics.. BMJ. 291(6506). 1375–1376. 12 indexed citations
17.
Begg, EJ, et al.. (1983). No significant effect of cimetidine on the pharmacokinetics of misonidazole in man.. British Journal of Clinical Pharmacology. 15(5). 575–576. 5 indexed citations
18.
Begg, EJ, et al.. (1982). Enhanced metabolism of mexiletine after phenytoin administration.. British Journal of Clinical Pharmacology. 14(2). 219–223. 30 indexed citations
19.
Begg, EJ, S. R. Munn, & Bailey Rr. (1979). Acebutolol in the treatment of patients with hypertension and renal functional impairment.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 89(634). 293–5. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026